Yusuf Yilmaz (Yusuf Yılmaz)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 46

Top Venues

Liver international : official journal of the International Association for the Study of the Liver

Alimentary pharmacology & therapeutics

The New England journal of medicine

Hepatology forum

Marmara Universitesi Tip Fakultesi

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Marmara Universitesi Tip Fakultesi

Turkey

Lecturer/Associate Professor :: Department of Gastroenterology

Publications

Yasser Mahrous Fouad, Takumi Kawaguchi, Yusuf Yilmaz
Impact of the MetALD terminology on the prevalence of alcohol-related fatty liver disease in US adults (2017-2020). Liver international : official journal of the International Association for the Study of the Liver (2024)
Zobair M Younossi, Pegah Golabi, James Paik, Soroor Owrangi, Yusuf Yilmaz, Mohamed El Kassas, Khaled A Alswat, Saleh A Alqahthani
Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa. Liver international : official journal of the International Association for the Study of the Liver 44 (4) (2024)
Gideon M Hirschfield, Christopher L Bowlus, Marlyn J Mayo, Andreas E Kremer, John M Vierling, Kris V Kowdley, Cynthia Levy, Alejandra Villamil, Alma L Ladrón de Guevara Cetina, Ewa Janczewska, Ehud Zigmond, Sook-Hyang Jeong, Yusuf Yilmaz, Yiannis Kallis, Christophe Corpechot, Peter Buggisch, Pietro Invernizzi, Maria Carlota Londoño Hurtado, Sandrin Bergheanu, Ke Yang, Yun-Jung Choi, Daria B Crittenden, Charles A McWherter, null null
A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis. The New England journal of medicine 390 (9) (2024)
Gideon M Hirschfield, Christopher L Bowlus, Marlyn J Mayo, Andreas E Kremer, John M Vierling, Kris V Kowdley, Cynthia Levy, Alejandra Villamil, Alma L Ladrón de Guevara Cetina, Ewa Janczewska, Ehud Zigmond, Sook-Hyang Jeong, Yusuf Yilmaz, Yiannis Kallis, Christophe Corpechot, Peter Buggisch, Pietro Invernizzi, Maria Carlota Londoño Hurtado, Sandrin Bergheanu, Ke Yang, Yun-Jung Choi, Daria B Crittenden, Charles A McWherter, null null
A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis. The New England journal of medicine 390 (9) (2024)
Gideon M Hirschfield, Christopher L Bowlus, Marlyn J Mayo, Andreas E Kremer, John M Vierling, Kris V Kowdley, Cynthia Levy, Alejandra Villamil, Alma L Ladrón de Guevara Cetina, Ewa Janczewska, Ehud Zigmond, Sook-Hyang Jeong, Yusuf Yilmaz, Yiannis Kallis, Christophe Corpechot, Peter Buggisch, Pietro Invernizzi, Maria Carlota Londoño Hurtado, Sandrin Bergheanu, Ke Yang, Yun-Jung Choi, Daria B Crittenden, Charles A McWherter, null null
A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis. The New England journal of medicine 390 (9) (2024)
Ferenc Emil Mózes, Jenny A Lee, Yasaman Vali, Emmanuel A Selvaraj, Arjun N A Jayaswal, Jérôme Boursier, Victor De Ledinghen, Monica Lupsor-Platon, Yusuf Yilmaz, Wah-Kheong Chan, Sanjiv Mahadeva, Thomas Karlas, Johannes Wiegand, null Shalimar, Emmanuel A Tsochatzis, Antonio Liguori, Vincent Wai-Sun Wong, Dae Ho Lee, Adriaan Georgius Holleboom, Anne-Marieke Van Dijk, Anne Linde Mak, Hannes Hagström, Camilla Akbari, Masashi Hirooka, Dong Hyeon Lee, Won Kim, Takeshi Okanoue, Toshihide Shima, Hirokazu Takahashi, Masato Yoneda, Paul J Thuluvath, Feng Li, Annalisa Berzigotti, Yuly P Mendoza, Mazen Noureddin, Emily Truong, Céline Fournier-Poizat, Andreas Geier, Theresa Tuthill, Carla Yunis, Quentin M Anstee, Stephen A Harrison, Patrick M Bossuyt, Michael Pavlides
Diagnostic accuracy of non-invasive tests to screen for at-risk MASH-An individual participant data meta-analysis. Liver international : official journal of the International Association for the Study of the Liver 44 (8) (2024)
Ferenc Emil Mózes, Jenny A Lee, Yasaman Vali, Emmanuel A Selvaraj, Arjun N A Jayaswal, Jérôme Boursier, Victor De Ledinghen, Monica Lupsor-Platon, Yusuf Yilmaz, Wah-Kheong Chan, Sanjiv Mahadeva, Thomas Karlas, Johannes Wiegand, null Shalimar, Emmanuel A Tsochatzis, Antonio Liguori, Vincent Wai-Sun Wong, Dae Ho Lee, Adriaan Georgius Holleboom, Anne-Marieke Van Dijk, Anne Linde Mak, Hannes Hagström, Camilla Akbari, Masashi Hirooka, Dong Hyeon Lee, Won Kim, Takeshi Okanoue, Toshihide Shima, Hirokazu Takahashi, Masato Yoneda, Paul J Thuluvath, Feng Li, Annalisa Berzigotti, Yuly P Mendoza, Mazen Noureddin, Emily Truong, Céline Fournier-Poizat, Andreas Geier, Theresa Tuthill, Carla Yunis, Quentin M Anstee, Stephen A Harrison, Patrick M Bossuyt, Michael Pavlides
Diagnostic accuracy of non-invasive tests to screen for at-risk MASH-An individual participant data meta-analysis. Liver international : official journal of the International Association for the Study of the Liver 44 (8) (2024)
Zobair M Younossi, Pegah Golabi, James Paik, Soroor Owrangi, Yusuf Yilmaz, Mohamed El Kassas, Khaled A Alswat, Saleh A Alqahthani
Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa. Liver international : official journal of the International Association for the Study of the Liver 44 (4) (2024)
Gideon M Hirschfield, Christopher L Bowlus, Marlyn J Mayo, Andreas E Kremer, John M Vierling, Kris V Kowdley, Cynthia Levy, Alejandra Villamil, Alma L Ladrón de Guevara Cetina, Ewa Janczewska, Ehud Zigmond, Sook-Hyang Jeong, Yusuf Yilmaz, Yiannis Kallis, Christophe Corpechot, Peter Buggisch, Pietro Invernizzi, Maria Carlota Londoño Hurtado, Sandrin Bergheanu, Ke Yang, Yun-Jung Choi, Daria B Crittenden, Charles A McWherter, null null
A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis. The New England journal of medicine 390 (9) (2024)
Gideon M Hirschfield, Christopher L Bowlus, Marlyn J Mayo, Andreas E Kremer, John M Vierling, Kris V Kowdley, Cynthia Levy, Alejandra Villamil, Alma L Ladrón de Guevara Cetina, Ewa Janczewska, Ehud Zigmond, Sook-Hyang Jeong, Yusuf Yilmaz, Yiannis Kallis, Christophe Corpechot, Peter Buggisch, Pietro Invernizzi, Maria Carlota Londoño Hurtado, Sandrin Bergheanu, Ke Yang, Yun-Jung Choi, Daria B Crittenden, Charles A McWherter, null null
A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis. The New England journal of medicine (2024)
Ziyan Pan, Yusuf Yilmaz, Said A Al-Busafi, Mohammed Eslam
The MAFLD definition identifies three homogenous groups of patients. Liver international : official journal of the International Association for the Study of the Liver (2024)
Zobair M Younossi, Pegah Golabi, James Paik, Soroor Owrangi, Yusuf Yilmaz, Mohamed El Kassas, Khaled A Alswat, Saleh A Alqahthani
Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa. Liver international : official journal of the International Association for the Study of the Liver 44 (4) (2024)
Zobair M Younossi, Pegah Golabi, James Paik, Soroor Owrangi, Yusuf Yilmaz, Mohamed El Kassas, Khaled A Alswat, Saleh A Alqahthani
Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa. Liver international : official journal of the International Association for the Study of the Liver 44 (4) (2024)
Ferenc Emil Mózes, Jenny A Lee, Yasaman Vali, Emmanuel A Selvaraj, Arjun N A Jayaswal, Jérôme Boursier, Victor De Ledinghen, Monica Lupsor-Platon, Yusuf Yilmaz, Wah-Kheong Chan, Sanjiv Mahadeva, Thomas Karlas, Johannes Wiegand, null Shalimar, Emmanuel A Tsochatzis, Antonio Liguori, Vincent Wai-Sun Wong, Dae Ho Lee, Adriaan Georgius Holleboom, Anne-Marieke Van Dijk, Anne Linde Mak, Hannes Hagström, Camilla Akbari, Masashi Hirooka, Dong Hyeon Lee, Won Kim, Takeshi Okanoue, Toshihide Shima, Hirokazu Takahashi, Masato Yoneda, Paul J Thuluvath, Feng Li, Annalisa Berzigotti, Yuly P Mendoza, Mazen Noureddin, Emily Truong, Céline Fournier-Poizat, Andreas Geier, Theresa Tuthill, Carla Yunis, Quentin M Anstee, Stephen A Harrison, Patrick M Bossuyt, Michael Pavlides
Diagnostic accuracy of non-invasive tests to screen for at-risk MASH-An individual participant data meta-analysis. Liver international : official journal of the International Association for the Study of the Liver (2024)
Vlad Ratziu, Yusuf Yilmaz, Don Lazas, Scott L Friedman, Caroline Lackner, Cynthia Behling, Oscar W Cummings, Li Chen, Mathieu Petitjean, Yossi Gilgun-Sherki, Tali Gorfine, Shaul Kadosh, Eli Eyal, Arun J Sanyal
Aramchol improves hepatic fibrosis in metabolic dysfunction-associated steatohepatitis: Results of multimodality assessment using both conventional and digital pathology. Hepatology (Baltimore, Md.) (2024)
Zobair M Younossi, Pegah Golabi, James Paik, Soroor Owrangi, Yusuf Yilmaz, Mohamed El Kassas, Khaled A Alswat, Saleh A Alqahthani
Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa. Liver international : official journal of the International Association for the Study of the Liver 44 (4) (2024)
Zobair M Younossi, Pegah Golabi, James Paik, Soroor Owrangi, Yusuf Yilmaz, Mohamed El Kassas, Khaled A Alswat, Saleh A Alqahthani
Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa. Liver international : official journal of the International Association for the Study of the Liver 44 (4) (2024)
Zobair M Younossi, Pegah Golabi, James Paik, Soroor Owrangi, Yusuf Yilmaz, Mohamed El Kassas, Khaled A Alswat, Saleh A Alqahthani
Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa. Liver international : official journal of the International Association for the Study of the Liver 44 (4) (2024)
Yusuf Yilmaz
Letter: Beyond advanced fibrosis-The critical need for assessing NITs performance in identifying F2-F3 fibrosis. Alimentary pharmacology & therapeutics (2024)
Zobair M Younossi, Pegah Golabi, James Paik, Soroor Owrangi, Yusuf Yilmaz, Mohamed El Kassas, Khaled A Alswat, Saleh A Alqahthani
Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa. Liver international : official journal of the International Association for the Study of the Liver (2024)
Yusuf Yilmaz
Editorial: "being normal weight each day keeps NAFLD and fibrosis away"-the importance of reducing cumulative exposure to overweight. Alimentary pharmacology & therapeutics 57 (10) (2023)
Yusuf Yilmaz
Editorial: "being normal weight each day keeps NAFLD and fibrosis away"-the importance of reducing cumulative exposure to overweight. Alimentary pharmacology & therapeutics 57 (10) (2023)
Yusuf Yilmaz
Editorial: "being normal weight each day keeps NAFLD and fibrosis away"-the importance of reducing cumulative exposure to overweight. Alimentary pharmacology & therapeutics 57 (10) (2023)
Yusuf Yilmaz
Editorial: "being normal weight each day keeps NAFLD and fibrosis away"-the importance of reducing cumulative exposure to overweight. Alimentary pharmacology & therapeutics 57 (10) (2023)
Gong Feng, Luca Vittorio Valenti, Vincent Wai-Sun Wong, Yasser Mahrous Fouad, Yusuf Yilmaz, Won Kim, Giada Sebastiani, Zobair M Younossi, Virginia Hernández-Gea, Ming-Hua Zheng
Recompensation in cirrhosis: unravelling the evolving natural history of nonalcoholic fatty liver disease. Nature reviews. Gastroenterology & hepatology (2023)
Yusuf Yilmaz, Zobair M Younossi
Editorial: changes of health-related quality of life associated with hepatic disease severity and its improvement after treatment in NAFLD-authors' reply. Alimentary pharmacology & therapeutics 57 (2) (2022)
Yusuf Yilmaz, Zobair M Younossi
Editorial: changes of health-related quality of life associated with hepatic disease severity and its improvement after treatment in NAFLD-authors' reply. Alimentary pharmacology & therapeutics 57 (2) (2022)
Eda Kaya, Yusuf Yilmaz
Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease. Therapeutic advances in endocrinology and metabolism 13 (2022)
Eda Kaya, Yusuf Yilmaz
Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease. Therapeutic advances in endocrinology and metabolism 13 (2022)
Eda Kaya, Guillermo D Mazzolini, Yusuf Yilmaz, Peter Lemmer
Prevention of hepatocellular carcinoma and monitoring of high-risk patients. Hepatology forum 3 (1) (2022)
Eda Kaya, Yusuf Yilmaz
Insidious danger for young adults: Metabolic (dysfunction)-associated fatty liver disease. Hepatology forum 3 (2) (2022)
Yusuf Yilmaz, Ahmet Eren Toraman, Ceyda Alp, Zehra Doğan, Caglayan Keklikkiran, Maria Stepanova, Zobair M Younossi
Impairment of patient-reported outcomes among patients with non-alcoholic fatty liver disease: a registry-based study. Alimentary pharmacology & therapeutics (2022)
Ferenc Emil Mózes, Jenny A Lee, Emmanuel Anandraj Selvaraj, Arjun Narayan Ajmer Jayaswal, Michael Trauner, Jérôme Boursier, Céline Fournier, Katharina Staufer, Rudolf E Stauber, Elisabetta Bugianesi, Ramy Youne, Silvia Gaia, Monica Lupșor-Platon, Salvatore Petta, Toshihide Shima, Takeshi Okanoue, Sanjiv Mahadeva, Wah-Kheong Chan, Peter J Eddowes, Gideon M Hirschfield, Philip Noel Newsome, Vincent Wai-Sun Wong, Victor de Ledinghen, Jiangao Fan, Feng Shen, Jeremy F Cobbold, Yoshio Sumida, Akira Okajima, Jörn M Schattenberg, Christian Labenz, Won Kim, Myoung Seok Lee, Johannes Wiegand, Thomas Karlas, Yusuf Yilmaz, Guruprasad Padur Aithal, Naaventhan Palaniyappan, Christophe Cassinotto, Sandeep Aggarwal, Harshit Garg, Geraldine J Ooi, Hirokazu Takahashi, Masato Yoneda, Marianne Ziol, Nathalie Barget, Andreas Geier, Theresa Tuthill, M Julia Brosnan, Quentin Mark Anstee, Stefan Neubauer, Stephen A Harrison, Patrick M Bossuyt, Michael Pavlides, null null
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis. Gut (2021)
Coskun Ozer Demirtas, Yusuf Yilmaz
Editorial: liver stiffness by magnetic resonance elastography and cardiovascular risk in non-alcoholic fatty liver disease-simply associated or more complicated? Alimentary pharmacology & therapeutics 53 (11) (2021)
Eda Kaya, Alev Bakır Kayı, Haluk Tarik Kani, Coskun Ozer Demirtas, Caglayan Keklikkiran, Yusuf Yilmaz
Simple Noninvasive Scores Are Clinically Useful to Exclude, Not Predict, Advanced Fibrosis: A Study in Turkish Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease. Gut and liver 14 (4) (2021)
Jeffrey Victor Lazarus, Henry E Mark, Quentin Mark Anstee, Juan Pablo Arab, Rachel L Batterham, Laurent Castera, Helena Cortez-Pinto, Javier Crespo, Kenneth Cusi, M Ashworth Dirac, Sven M Francque, Jacob George, Hannes Hagström, Terry T K Huang, Mona H Ismail, Achim Kautz, Shiv Kumar Sarin, Stephen Caldwell, Veronica Miller, Philip N Newsome, Michael Ninburg, Ponsiano Ocama, Vlad Ratziu, Mary Rinella, Diana Romero, Manuel Romero, Jörn Markus Schattenberg, Emmanuel A Tsochatzis, Luca Valenti, Vincent Wai-Sun Wong, Yusuf Yilmaz, Zobair M Younossi, Shira Zelber-Sagi, null null
Advancing the global public health agenda for NAFLD: a consensus statement. Nature reviews. Gastroenterology & hepatology (2021)
Yusuf Yilmaz, Nimet Yılmaz, Fehmi Ates, Fatih Karakaya, Hale Gökcan, Eda Kaya, Gupse Adali, Aysun Caliskan Kartal, Ilker Sen, Emel Ahishali, Seren Ozenirler, Mehmet Koruk, Ahmet Uygun, Ramazan İdilman, null null, null null
The prevalence of metabolic-associated fatty liver disease in the Turkish population: A multicenter study. Hepatology forum 2 (2) (2021)
Ilkay Ergenc, Pinar Gokcen, Gupse Adali, Haluk Tarik Kani, Coskun Ozer Demirtas, Feyza Gunduz, Çiğdem Ataizi Çelikel, Yusuf Yilmaz
High incidence of hepatitis B core antibody positivity in metabolic-associated fatty liver disease-related cirrhosis. Hepatology forum 2 (1) (2021)
Coskun Ozer Demirtas, Caglayan Keklikkiran, Ilkay Ergenc, Buket Ertürk Sengel, Güneş Eskidemir, Ismail Cinel, Zekaver Odabaşı, Volkan Korten, Yusuf Yilmaz
Liver stiffness is associated with disease severity and worse clinical scenarios in coronavirus disease 2019: A prospective transient elastography study. International journal of clinical practice 75 (9) (2021)
Eda Kaya, Yusuf Yilmaz
Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver. Journal of clinical and translational hepatology 10 (2) (2021)
Yusuf Yilmaz, Christopher D Byrne, Giovanni Musso
A single-letter change in an acronym: signals, reasons, promises, challenges, and steps ahead for moving from NAFLD to MAFLD. Expert review of gastroenterology & hepatology 15 (4) (2020)
Tasnim Alkayyali, Lubna Qutranji, Eda Kaya, Alev Bakir, Yusuf Yilmaz
Clinical utility of noninvasive scores in assessing advanced hepatic fibrosis in patients with type 2 diabetes mellitus: a study in biopsy-proven non-alcoholic fatty liver disease. Acta diabetologica 57 (5) (2020)
Yusuf Yilmaz
Letter: a stepwise approach towards the screening of hepatic fibrosis in the general population. Alimentary pharmacology & therapeutics 51 (6) (2020)
Yusuf Yilmaz, Eda Kaya, Fatih Eren
Letter: the use of Fibrosis-4 score in primary care and diabetology practices-Occam's razor applied to advanced fibrosis screening. Alimentary pharmacology & therapeutics 52 (11-12) (2020)
Yusuf Yilmaz
Letter: the perilous road to a functional cure for hepatitis B infection. Alimentary pharmacology & therapeutics 51 (5) (2020)
Yusuf Yilmaz, Fatih Eren
NFS Is Not a Marker of Nonalcoholic Fatty Liver Disease Per Se: What Is the True Relationship With CAD Complexity? Angiology 71 (1) (2019)

Yusuf Yilmaz.css-eqlu8i{font-size:small;padding-left:4px;} (Yusuf Yılmaz)

Publication Activity (10 Years)

Top Topics

Top Venues

Yusuf Yilmaz (Yusuf Yılmaz)